Trial
NCT03947190
A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults
Phase IITERMINATEDREGULATORYConfidence: HIGH
Sponsor
University of Oxford
Collaborators
Kenya Medical Research Institute; European and Developing Countries Clinical Trials Partnership (EDCTP)
Condition
Malaria,Falciparum
Intervention
R21/Matrix-M
Why stopped
Due to US FDA hold on the challenge agent and funding concerns
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-20